文献速递脑血管病

散发性脑淀粉样血管病相关急性凸面蛛网膜下腔出血的发病率与预后:基于人群研究

Incidence and Prognosis of Acute Convexity Subarachnoid Hemorrhage in Sporadic Cerebral Amyloid Angiopathy: A Population-Based Study.
PubMed 文献 · Stroke · 2025-09-18

本研究在法国诺曼底卒中研究队列中前瞻性识别首次凸面蛛网膜下腔出血(cSAH)且符合Boston 2.0 probable CAA标准的患者,标准化后50岁以上人群cSAH继发CAA的发病率为1.7/10万人年(95%CI 1.0-2.7),3年脑出血累积风险30.0%(95%CI 10.2-53.0),死亡累积风险21.8%(95%CI 0.0-41.2)。结论提示该事件在人群层面仍罕见,但随访期脑出血风险高,需准确识别,尤其≥70岁伴短暂神经症状者。

要点

  • 50岁以上人群CAA相关cSAH标准化发病率为1.7/10万人年。
  • CAA相关cSAH患者3年脑出血累积风险达30.0%。
  • ≥70岁伴短暂神经症状者应警惕CAA相关cSAH。

核心结论

  • 急性cSAH继发于CAA在人群层面仍属罕见事件。
  • 随访期间脑出血风险高,强调准确识别cSAH的重要性。

研究设计与样本

  • 基于法国Caen Normandy Metropole人群的前瞻性诺曼底卒中研究。
  • 在≥50岁人群中按2013年欧洲人口标准化计算发病率。
  • 以死亡为竞争风险计算后续脑出血累积风险。

主要发现

  • 193例首次SAH中27例(14.0%)为cSAH,18例(9.3%)符合Boston 2.0 probable CAA标准(平均年龄79岁,女性66.7%)。
  • 符合CAA标准的18例中17例(94.4%)年龄≥70岁,16例(88.9%)表现为短暂神经症状。
  • ≥50岁人群CAA相关cSAH标准化发病率为1.7/10万人年(95%CI 1.0-2.7)。
  • 3年脑出血累积风险30.0%(95%CI 10.2-53.0),死亡累积风险21.8%(95%CI 0.0-41.2)。

关键数值与推荐

  • CAA相关cSAH诊断依据Boston 2.0 probable CAA标准。
  • 发病率标准化参照2013年欧洲人口。
  • 竞争风险模型用于计算脑出血累积风险。

临床怎么用

  • 对≥70岁出现短暂神经症状者应怀疑cSAH并评估CAA可能。
  • 确诊CAA相关cSAH后需警惕随访期脑出血风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cerebral amyloid angiopathy (CAA) is a common cause of acute convexity subarachnoid hemorrhage (cSAH). We aimed to report the incidence and prognosis of cSAH secondary to CAA in a population-based cohort. METHODS: The Normandy Stroke Study prospectively identified people with SAH in Caen Normandy Metropole (France). This analysis included participants with a first-ever cSAH that met the Boston 2.0 criteria for probable CAA and occurred between May 15, 2017, and December 31, 2023. The incidence of cSAH secondary to CAA was determined in individuals aged ≥50 years after standardization to the 2013 European population. The cumulative risk of subsequent intracerebral hemorrhage was calculated with death as a competing event. RESULTS: Among 193 participants with a first-ever SAH, 27 (14.0%) had a cSAH, and 18 (9.3%) met the Boston 2.0 criteria for probable CAA (mean age 79 years, 66.7% women). Among these, 17 (94.4%) were aged ≥70 years, and 16 (88.9%) presented with transient neurological symptoms. The standardized incidence of cSAH secondary to CAA was 1.7 per 100 000 person-years (95% CI, 1.0-2.7) at ages ≥50 years. Three-year cumulative risks were 30.0% (95% CI, 10.2-53.0) for intracerebral hemorrhage and 21.8% (95% CI, 0.0-41.2) for death. CONCLUSIONS: Acute cSAH secondary to CAA remains a rare event at the population level. The high risk of intracerebral hemorrhage during follow-up underscores the importance of accurately identifying cSAH, particularly in people aged ≥70 years presenting with transient neurological symptoms.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Crinière-Boizet L, Watrin M, Braux G, et al. Incidence and Prognosis of Acute Convexity Subarachnoid Hemorrhage in Sporadic Cerebral Amyloid Angiopathy: A Population-Based Study. Stroke. 2025. PMID: 40964712. doi:10.1161/STROKEAHA.125.052558

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。